Skip to main content

Cigna Value Stock - Dividend - Research Selection

Cigna

ISIN: US1255231003 , WKN: A2PA9L

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Cigna Corporation, a health services organization, provides insurance and related products and services in the United States and internationally. It operates through Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations segments. The Global Health Care segment offers medical, dental, behavioral health, vision, and prescription drug benefit plans, as well as health advocacy programs, and other products and services to insured and self-insured customers. This segment also provides Medicare Advantage and Medicare Part D plans to seniors, and Medicaid plans. The Global Supplemental Benefits segment offers supplemental health, life, and accident insurance products. The Group Disability and Life segment provides group long-term and short-term disability, group life, accident, and specialty insurance products and related services. The Other Operations segment offers corporate-owned life insurance products that are permanent insurance contracts sold to corporations to provide coverage; and run-off settlement annuity contracts. The company distributes its products and services through insurance brokers and insurance consultants; and directly to employers, unions and other groups, or individuals, as well as through direct response television and the Internet. Cigna Corporation was founded in 1792 and is headquartered in Bloomfield, Connecticut.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Will Declining Medical Membership Affect Humana's Q4 Earnings?

2026-02-06
HUM heads into Q4 with declining medical membership and rising costs, clouding earnings despite expectations for solid revenue growth.

Centene Incurs Q4 Loss, Revenues Up YoY due to PDP Business Strength

2026-02-06
CNC incurs a Q4 adjusted loss per share as medical costs spike, but revenues jump nearly 22% on strong PDP and Marketplace premium growth.

Dividend Champion, Contender, And Challenger Highlights: Week Of February 8

2026-02-06
Get this week’s dividend updates for Dividend Champions, Contenders & Challengers—see dividend changes, upcoming ex-dividend dates and pay dates. Read the full analysis here.

Cigna Shows Greater Stability Amid Policy Uncertainty, RBC Says

2026-02-06
Cigna Group (CI) shows greater stability as its managed care organization peers face policy headwind

Molina Healthcare Incurs a Loss in Q4 as Medical Costs Surge

2026-02-06
Molina Healthcare posts Q4 loss as medical costs surge, even as revenues rise 8% and full-year sales top expectations.

Cigna Group Q4 Earnings Call Highlights

2026-02-06
Cigna Group (NYSE:CI) executives highlighted double-digit revenue growth in 2025, a modestly higher 2026 earnings outlook, and a major regulatory development during the company’s fourth-quarter 2025 earnings call. Management also discussed continued investment to support a new “rebate-free” pharmacy

CI Q4 Deep Dive: PBM Model Transition and Specialty Growth Drive Positive Results

2026-02-06
Health insurance company Cigna (NYSE:CI) reported revenue ahead of Wall Street’s expectations in Q4 CY2025, with sales up 10.4% year on year to $72.5 billion. On the other hand, the company’s full-year revenue guidance of $280 billion at the midpoint came in 0.9% below analysts’ estimates. Its non-GAAP profit of $8.08 per share was 2.5% above analysts’ consensus estimates.

Trump Touts Drug Cost Savings as He Launches TrumpRx Website

2026-02-06
“Starting tonight, dozens of the most commonly used prescription drugs will be available at dramatic discounts for all consumers through a new website, TrumpRx.gov,” Trump said at a White House event Thursday to hail the new effort. The administration has touted its efforts to lower the cost of drugs, including by negotiating agreements with more than a dozen of the world’s largest pharmaceutical companies, including Eli Lilly & Co., Novo Nordisk A/S and Pfizer Inc., often in exchange for a reduction in threatened tariffs.

The Cigna Group (CI) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ...

2026-02-05
The Cigna Group (CI) reports an 11% increase in full-year adjusted revenue, with strategic investments and a new PBM model aligning with regulatory expectations.

Cigna Q4 Earnings Beat Estimates on Higher Specialty Volumes

2026-02-05
CI's Q4 adjusted EPS beats estimates as Evernorth growth and higher specialty volumes offset fewer medical customers and elevated costs.